These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18045611)

  • 1. Identification of prostate cancer antigens by automated high-throughput filter immunoscreening.
    Alsøe L; Stacy JE; Fosså A; Funderud S; Brekke OH; Gaudernack G
    J Immunol Methods; 2008 Jan; 330(1-2):12-23. PubMed ID: 18045611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.
    Fosså A; Alsøe L; Crameri R; Funderud S; Gaudernack G; Smeland EB
    Cancer Immunol Immunother; 2004 May; 53(5):431-8. PubMed ID: 14747957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of tumour antigens by serological analysis of cDNA expression cloning.
    Li G; Miles A; Line A; Rees RC
    Cancer Immunol Immunother; 2004 Mar; 53(3):139-43. PubMed ID: 14722670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NY-ESO-1 expression and immunogenicity in prostate cancer patients.
    Gati A; Lajmi N; Derouiche A; Marrakchi R; Chebil M; Benammar-Elgaaied A
    Tunis Med; 2011 Oct; 89(10):779-83. PubMed ID: 22076902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.
    Mischo A; Wadle A; Wätzig K; Jäger D; Stockert E; Santiago D; Ritter G; Regitz E; Jäger E; Knuth A; Old L; Pfreundschuh M; Renner C
    Cancer Immun; 2003 Jun; 3():5. PubMed ID: 12828452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.
    Kawada J; Wada H; Isobe M; Gnjatic S; Nishikawa H; Jungbluth AA; Okazaki N; Uenaka A; Nakamura Y; Fujiwara S; Mizuno N; Saika T; Ritter E; Yamasaki M; Miyata H; Ritter G; Murphy R; Venhaus R; Pan L; Old LJ; Doki Y; Nakayama E
    Int J Cancer; 2012 Feb; 130(3):584-92. PubMed ID: 21413013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human tumor antigens by serological analysis of recombinant cDNA expression libraries (SEREX).
    Scanlan MJ
    Curr Protoc Immunol; 2005 Mar; Chapter 20():Unit 20.7. PubMed ID: 18432945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.
    Chen YT; Scanlan MJ; Sahin U; Türeci O; Gure AO; Tsang S; Williamson B; Stockert E; Pfreundschuh M; Old LJ
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1914-8. PubMed ID: 9050879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.
    Nakada T; Noguchi Y; Satoh S; Ono T; Saika T; Kurashige T; Gnjatic S; Ritter G; Chen YT; Stockert E; Nasu Y; Tsushima T; Kumon H; Old LJ; Nakayama E
    Cancer Immun; 2003 Jul; 3():10. PubMed ID: 12889868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard treatments induce antigen-specific immune responses in prostate cancer.
    Nesslinger NJ; Sahota RA; Stone B; Johnson K; Chima N; King C; Rasmussen D; Bishop D; Rennie PS; Gleave M; Blood P; Pai H; Ludgate C; Nelson BH
    Clin Cancer Res; 2007 Mar; 13(5):1493-502. PubMed ID: 17332294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
    Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
    Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomic analysis of human sarcoma.
    Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reverse proteomics for identification of tumor antigens.
    Lee SY; Jeoung D
    J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of lymphoma-associated antigens using SEREX.
    Liggins AP; Guinn BA; Banham AH
    Methods Mol Med; 2005; 115():109-28. PubMed ID: 15998965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
    Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
    Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma.
    Ali Eldib AM; Ono T; Shimono M; Kaneko M; Nakagawa K; Tanaka R; Noguchi Y; Nakayama E
    Int J Cancer; 2004 Feb; 108(4):558-63. PubMed ID: 14696120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological analysis of expression cDNA libraries (SEREX): an immunoscreening technique for identifying immunogenic tumor antigens.
    Chen YT; Gure AO; Scanlan MJ
    Methods Mol Med; 2005; 103():207-16. PubMed ID: 15542909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoscreening of urinary bladder cancer cDNA library and identification of potential tumor antigen.
    Chen L; Chen W; Zhao L; Yu HZ; Li X
    World J Urol; 2009 Feb; 27(1):107-12. PubMed ID: 18828023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
    Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A
    Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential target antigens for immunotherapy identified by serological expression cloning (SEREX).
    Jäger D
    Methods Mol Biol; 2007; 360():319-26. PubMed ID: 17172736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.